ARCHIVES

FDA Authority To Remove Paclitaxel Patent Questioned.

This article is from The Cancer Letter archive.

Vol. 27 No. 06 | February 9, 2001

Download PDF Visit The Full Archive

Related Articles

Computer Interpretation Software Does Not Improve Detection

August 26, 2011

Computer Sciences Corp. Wins NIH Information System Contract

September 20, 2002

NCI Human Tissue Network Resources Available For Research

January 24, 1997

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

June 27, 2014

Funding Opportunities.

April 12, 2002

UICC Receives 1300 Abstracts For Congress In Oslo, Norway.

February 22, 2002